GL1X · GenesisL1 explorer

MolNFT v1 · #143306 · protein

Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes

6AVO · Proteasome subunit beta type-9: “Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits…”. Electron microscopy, 1 ligand (BZ7), 20 pockets (best druggability 0.80). MolNFT v1…

PDB
6AVO
Type
protein
Length
6,192 residues
Chains
28
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proteasome subunit beta type-9; Proteasome subunit beta type-10; Proteasome subunit beta…
EC
3.4.25.1
UniProt
P28065, P40306, P28062, P25786, P28066, O14818, P25788, P60900, P25789, P25787, P20618, P49721, P49720, P28070
Ligands
BZ7
Pockets
20 · best druggability 0.80

Structure

electron microscopy · 14 distinct chains · 34% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, FProteasome subunit beta type-9 (EC 3.4.25.1)protein19934% helix, 25% strandP28065
B, EProteasome subunit beta type-10 (EC 3.4.25.1)protein21930% helix, 26% strandP40306
C, DProteasome subunit beta type-8 (EC 3.4.25.1)protein20135% helix, 29% strandP28062
G, LProteasome subunit alpha type-1 (EC 3.4.25.1)protein23431% helix, 24% strandP25786
H, MProteasome subunit alpha type-5 (EC 3.4.25.1)protein23332% helix, 23% strandP28066
I, NProteasome subunit alpha type-7 (EC 3.4.25.1)protein23237% helix, 22% strandO14818
J, QProteasome subunit alpha type-3 (EC 3.4.25.1)protein23936% helix, 23% strandP25788
K, RProteasome subunit alpha type-6 (EC 3.4.25.1)protein24034% helix, 23% strandP60900
O, ZProteasome subunit alpha type-4 (EC 3.4.25.1)protein24036% helix, 24% strandP25789
P, bProteasome subunit alpha type-2 (EC 3.4.25.1)protein23035% helix, 22% strandP25787
S, XProteasome subunit beta type-1 (EC 3.4.25.1)protein21331% helix, 29% strandP20618
T, VProteasome subunit beta type-2 (EC 3.4.25.1)protein19633% helix, 32% strandP49721
U, YProteasome subunit beta type-3 (EC 3.4.25.1)protein20432% helix, 26% strandP49720
W, aProteasome subunit beta type-4 (EC 3.4.25.1)protein21634% helix, 30% strandP28070

Ligands and binding sites

  • BZ7 · N~1~-{2-[([1,1'-biphenyl]-3-carbonyl)amino]ethyl}-N~4~-tert-butyl-N~2~-(3-phenylpropanoyl)-L-aspartamide · ligand · 2 copies · chains C, X, D, S

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110730.800.81105empty
27310.800.8481empty
39240.790.8187empty
410410.790.81136BZ7
57420.790.8381empty

Interfaces

86 interfaces between chains.

  • N–O · 1505 Ų buried · 21 hydrogen bonds · protein-protein
  • I–Z · 1468 Ų buried · 20 hydrogen bonds · protein-protein
  • E–U · 1465 Ų buried · 21 hydrogen bonds · protein-protein
  • B–Y · 1457 Ų buried · 23 hydrogen bonds · protein-protein
  • Z–b · 1433 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 6AVO · Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that… · the same entry in another collection · chain S against S, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.